Fact.MR – A Market Research and Competitive Intelligence Provider: The global primary cell culture market is expected to develop at an 11.6% CAGR from 2021 to 2031.
Reagents and Supplements Segment to Bank the Largest Revenue Share in the Primary Cell Culture Market
The Fact.MR report on primary cell culture market offers detailed analysis on the key growth drivers, restrains, and trends affecting demand in the market. The study also provides insights into the competitive landscape of global primary cell culture market, identifying the key market players and analyzing the impact of their growth strategies.
Fact.MR – A Market Research and Competitive Intelligence Provider: The global primary cell culture market is expected to develop at an 11.6% CAGR from 2021 to 2031. Diabetes mellitus, cancer, cardiovascular illnesses, autoimmune disorders, and nephrological diseases are all on the rise, which is fueling market expansion. As a result, research has increased, and primary cell cultures have been more widely adopted.
According to Globocan, in the year 2020, there would be about 19,292,789 cancer cases and around 9,958,133 cancer deaths. This significant rise in cancer incidence would increase demand for innovative therapies around the world, providing a profitable growth opportunity for the primary cell culture market over the forecast period.
Furthermore, the global incidence of cancer is steadily increasing. According to WHO forecasts, the number of cancer deaths worldwide would continue to climb, reaching over 13.1 billion by 2030. It also predicts a 75% increase in global cancer prevalence between 2008 and 2030. The rising incidence of cancer around the world is expected to increase demand for novel therapies, propelling the primary cell culture market forward in the coming years.
For Critical Insights On This Market, Request For More Info
https://www.factmr.com/connectus/sample?flag=S&rep_id=6253
To increase their product line, companies in the market are developing new products for primary cell cultures. For example, in January 2021, Lonza, a Swiss multinational chemicals and biotechnology business, introduced new customizable and high-quality cryo-preserved Leukopaks. As a result, market growth is expected to be fueled by the release of these new primary cell cultures products.
COVID-19 has had a negative influence on the life science industry, especially primary cell culture. However, with the current COVID-19 pandemic, researchers and producers have an opportunity to develop new solutions employing primary cell culture to control the virus’s new variants.
“Leading market players are investing in R&D for understanding the new variants of coronavirus with the application of primary cell culture. Besides this, they are increasingly using primary cell culture for developing an effective vaccine against COVID-19 virus. Such initiatives spurred demand in the market amid pandemic,” said a Fact.MR analyst.
Key Takeaways
- Due to the increased incidence of chronic diseases, the United States will dominate the primary cell cultures market with the greatest revenue share in 2020.
- Increased government funding in cell culture research and medication development, as well as the presence of major biopharmaceutical businesses, have boosted market growth in the United Kingdom.
- Due to the cheap cost of stem cell transplantation in the region, Asia Pacific is expected to be the fastest-growing market for primary cell culture.
- The reagents and supplements segment accounts for the largest revenue share due to increasing application for maintaining primary cell viability.
- Due to the increased focus on the development of COVID-19 vaccines, vaccine production is dominating the application segment.
Growth Drivers:
- The demand for primary cell culture will be fueled by increased research into new therapies.
- Sales of primary cell culture will increase as the prevalence of cancer, autoimmune illnesses, chronic infections, and diabetes mellitus rises.
- The market will grow as a result of a growing focus on understanding biological processes and molecular mechanisms of the cell.
- As a result of the coronavirus outbreak, demand for primary cell culture has increased.
Key Restraints:
- The growth of primary cell culture is hampered by a lack of highly optimized culture conditions.
- Demand for primary cell culture is being hampered by the high expense of doing so.
- The market’s expansion is being hampered by a lack of experience and skill.
To learn more about Primary Cell Culture Market, you can get in touch with our Analyst at
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6253
Competitive Landscape
Key players operating in the market are engaging in strategic collaborations and acquisition to maintain their position in the global market.
- Thermo Fisher Scientific Inc. announced it’s collaborated with Lyell Immunopharma to develop more effective cell therapies for cancer patients.
- In 2020, Charles River Laboratories acquired HemaCare Corporation to help expanding Charles River’s capabilities in the high-growth cell therapy sector.
- In 2020, BioIVT, the U.S. based company, introduced high-purity Kupffer cells to its portfolio of human primary hepatic cells to support liver disease drug discovery and development.
Prominent Players in the Primary Cell Culture Market are -
- Merck KGaA
- Danaher
- Thermo Fisher Scientific Inc.
- Lonza
- Corning Incorporated
- PromoCell GmbH
- FUJIFILM
- Irvine Scientific Inc.
- Axol Bioscience Ltd.
- Mattek
- STEMCELL Technologies Inc.
- HiMedia Laboratories Pvt Ltd
- ATCC
More Valuable Insights on Primary Cell Culture Market
Fact.MR, in its new report, offers an unbiased analysis of the global primary cell culture market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in primary cell culture market with detailed segmentation:
By Product
- Primary Cells
- Human Primary Cells
- Animal Primary Cells
- Reagents & Supplements
- Media
By Application
- Tissue Culture & Tissue Engineering
- Vaccine Production
- Gene Therapy and Regenerative Medicine
- Virology
- Stem Cell Therapy
- Others
By End User
- Life Science Research Companies
- Research Institutes
By Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Key Questions Covered in the Primary Cell Culture Market Report
- The market survey also highlights projected sales growth for primary cell culture market between 2021 and 2031
- The report offers insight into primary cell culture demand outlook for forecast period 2021-2031
- Primary cell culture market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
- Primary cell culture market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
Explore Fact.MR’s Coverage on the Healthcare Domain -
Cell Lines Market Insights - increasing technical improvements in the healthcare industry, new discoveries, and higher investment in research and development have resulted in the discovery of many cell line paradigms, propelling the global cell lines market forward.
Flow Cytometry Market Analysis - As pharmaceutical and healthcare companies work to create advanced cancer diagnostics, the future prospects are likely to grow. As the COVID-19 pandemic raged, pharmaceutical companies pooled their resources to develop effective medication and vaccine compositions.
Isogenic Cell Lines Market Forecast - The market has grown as demand for isogenic cell lines in cancer research has increased. The CRISPR technology, which was developed recently, allows for genome editing and can be used to change one’s genetic makeup. It boosted the use of isogenic cell lines in clinical trials.
Cell Proliferation Assay Market Trends – The cell proliferation assay market is expanding due to rising demand for proliferation assays for cancer detection. Cell proliferation assays are used in cancer diagnostics to determine tumor aggressiveness and have become an important aspect of the process.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR